NDC 16571-833

Pryidostigmine Bromide

Pyridostigmine Bromide

Pryidostigmine Bromide is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is Pyridostigmine Bromide.

Product ID16571-833_b46177b2-68dc-4958-a4ec-d4bd6d887456
Product TypeHuman Prescription Drug
Proprietary NamePryidostigmine Bromide
Generic NamePyridostigmine Bromide
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2022-09-15
Marketing CategoryANDA /
Application NumberANDA208797
Labeler NameRising Pharma Holdings, Inc.
Active Ingredient Strength60 mg/5mL
Pharm ClassesCholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31


NDC 16571-833-16

473 mL in 1 BOTTLE, PLASTIC (16571-833-16)
Marketing Start Date2022-09-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pryidostigmine Bromide" or generic name "Pyridostigmine Bromide"

NDCBrand NameGeneric Name
13811-716Pryidostigmine BromidePyridostigmine Bromide
16571-833Pryidostigmine BromidePyridostigmine Bromide
24689-104PRYIDOSTIGMINE BROMIDEpyridostigmine bromide
0187-3010Mestinonpyridostigmine bromide
0187-3012Mestinonpyridostigmine bromide
0187-3013Mestinonpyridostigmine bromide
0115-1404Pyridostigmine BromidePYRIDOSTIGMINE BROMIDE
0115-2134Pyridostigmine BromidePYRIDOSTIGMINE BROMIDE
0115-3511Pyridostigmine BromidePYRIDOSTIGMINE BROMIDE
0904-6622pyridostigmine bromidepyridostigmine bromide
47781-335Pyridostigmine BromidePyridostigmine Bromide
50268-638Pyridostigmine BromidePyridostigmine Bromide
58657-810Pyridostigmine BromidePYRIDOSTIGMINE BROMIDE
0781-3040RegonolPyridostigmine Bromide

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.